| Course | HLTH 8574 Women's Health Issues |
|---|---|
| Week | Week 5 |
| Paper type | Condition brief |
| Length | About 620 words, 5 pages |
| Format | APA 7 student paper |
| School | Walden University |
| Program | PhD in Public Health |
| Updated | October 2026 |
Free sample paper for HLTH 8574 Week 5
Condition Brief: Sjögren's Disease in Women, With Every Epidemiologic Claim Dated and Tagged With the Classification Criteria Its Evidence Used, From the 2002 American-European Rules to the 2016 ACR/EULAR Score
Student Name
Walden University
HLTH 8574: Women's Health Issues
Instructor Name
Month Day, Year
Condition Brief: Sjögren's Disease in Women, With Every Epidemiologic Claim Dated and Tagged With the Classification Criteria Its Evidence Used, From the 2002 American-European Rules to the 2016 ACR/EULAR Score
Why Date the Evidence
Sjögren's disease is an autoimmune condition in which the immune system attacks the glands that make tears and saliva, causing dry eyes and dry mouth, and it can also affect joints, lungs, kidneys and nerves. It is diagnosed far more often in women than in men. Statements like that are easy to repeat, but the evidence behind them was produced at different times under different definitions of who counted as a case. This brief presents the condition with each claim dated and tagged with the classification criteria used, so a reader can tell which layer of evidence a statement rests on.
Three Sets of Classification Criteria
Classification criteria are built to define study populations, not to diagnose individual patients, and they have changed twice in two decades.
The 2002 rules let symptoms count toward classification (Vitali et al., 2002). The 2012 rules dropped symptoms and relied on objective tests (Shiboski et al., 2012). The 2016 rules combined features of both into a weighted score designed for use in clinical trials (Shiboski et al., 2017). A study using one set can include people another set would exclude.
Table 1
Classification Criteria for Sjögren's Disease and What Each Requires
| Criteria set | Year | What it requires | Tag used below | |
|---|---|---|---|
| American-European Consensus Group | 2002 | Four of six items, including either a positive lip biopsy or autoantibodies; or three of the four objective items | AECG 2002 | |
| American College of Rheumatology | 2012 | Two of three objective items: autoantibodies, lip biopsy focus score of 1 or more, ocular staining score of 3 or more | ACR 2012 | |
| ACR/EULAR | 2016 | Weighted score of 4 or more from biopsy, anti-SSA antibodies, ocular staining, tear test and unstimulated saliva flow | ACR/EULAR 2016 | |
Summaries follow Vitali et al. (2002), Shiboski et al. (2012) and Shiboski et al. (2017); each set also lists exclusions.
How Common and in Whom
A 2015 meta-analysis pooled 21 studies and estimated an incidence of 6.92 cases per 100,000 person-years and a prevalence of 60.82 per 100,000, falling to 43.03 per 100,000 when only population-based studies were included (Qin et al., 2015). Tag: mixed criteria, studies published before 2015, most predating ACR/EULAR 2016. The same analysis estimated a female-to-male ratio of 9.15 in incidence data and 10.72 in prevalence data, with a mean age at study of about 56 years. Tag: mixed criteria.
These figures cannot be read as current rates under the 2016 criteria, because no pooled estimate in this brief uses those criteria alone. They also vary widely by country and study design, which the authors themselves emphasize.
Why the Female Predominance Matters for Women's Health
A ratio near ten women to every man means most people living with the condition are women, many in midlife, and its symptoms of dryness, fatigue and joint pain overlap with those of perimenopause. That overlap can delay recognition. Women whose dry eyes or dry mouth are attributed to age or menopause may not be tested for the antibodies or offered the biopsy that classification depends on. Since every set of criteria requires objective testing, women who never reach testing are invisible to the epidemiology as well as to care.
Limits of This Brief
No current U.S. prevalence appears here, because the pooled figures are international, mixed in criteria and older than the 2016 rules. Nor is any one set of criteria treated as correct, since each was designed for a purpose. The single claim made is that a reader should ask, for every number about this condition, which year it comes from and which criteria counted the cases.
References
Qin, B., Wang, J., Yang, Z., Yang, M., Ma, N., Huang, F., & Zhong, R. (2015). Epidemiology of primary Sjögren's syndrome: A systematic review and meta-analysis. Annals of the Rheumatic Diseases, 74(11), 1983-1989. https://doi.org/10.1136/annrheumdis-2014-205375
Shiboski, C. H., Shiboski, S. C., Seror, R., Criswell, L. A., Labetoulle, M., Lietman, T. M., Rasmussen, A., Scofield, H., Vitali, C., Bowman, S. J., & Mariette, X. (2017). 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome: A consensus and data-driven methodology involving three international patient cohorts. Arthritis & Rheumatology, 69(1), 35-45. https://doi.org/10.1002/art.39859
Shiboski, S. C., Shiboski, C. H., Criswell, L. A., Baer, A. N., Challacombe, S., Lanfranchi, H., Schiødt, M., Umehara, H., Vivino, F., Zhao, Y., Dong, Y., Greenspan, D., Heidenreich, A. M., Helin, P., Kirkham, B., Kitagawa, K., Larkin, G., Li, M., Lietman, T., . . . Daniels, T. E. (2012). American College of Rheumatology classification criteria for Sjögren's syndrome: A data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort. Arthritis Care & Research, 64(4), 475-487. https://doi.org/10.1002/acr.21591
Vitali, C., Bombardieri, S., Jonsson, R., Moutsopoulos, H. M., Alexander, E. L., Carsons, S. E., Daniels, T. E., Fox, P. C., Fox, R. I., Kassan, S. S., Pillemer, S. R., Talal, N., & Weisman, M. H. (2002). Classification criteria for Sjögren's syndrome: A revised version of the European criteria proposed by the American-European Consensus Group. Annals of the Rheumatic Diseases, 61(6), 554-558. https://doi.org/10.1136/ard.61.6.554
What the HLTH 8574 Week 5 instructions ask for
Students prepare a brief on a condition that affects women disproportionately, focusing on its burden, distribution and the evidence behind those figures. Faculty expect the brief to define the condition clearly, report epidemiologic figures accurately and show awareness of how case definitions affect the numbers. Many prompts ask students to date and source each claim so readers can judge how current and comparable the evidence is. A table summarizing case definitions or classification criteria is useful when they have changed over time. The brief should explain why the condition matters for women's health in particular, beyond its sex ratio. It should also state its limits, including any figures it cannot provide, rather than presenting old or mixed estimates as current rates.
How this HLTH 8574 Week 5 example is built
The brief opens by defining Sjögren's disease and explaining why each claim will be dated and tagged. Table 1 summarizes the 2002, 2012 and 2016 classification criteria, citing Vitali and colleagues and the two Shiboski groups. A paragraph explains how each set changed who counts as a case. The epidemiology section reports Qin and colleagues' pooled incidence, prevalence and female-to-male ratios, each tagged as mixed criteria, and explains why those figures cannot be read as current rates under the 2016 criteria. A section on women's health discusses overlap with perimenopausal symptoms and the risk that women never reach the testing classification requires. A closing section lists what the brief does not claim and the questions a reader should ask of any figure.
HLTH 8574 Week 5 rubric: what earns full marks
Faculty grade the condition brief on accuracy and on how clearly it handles the evidence. Correct definitions and figures are the foundation, and errors in criteria or rates cost significant credit. Credit rises when each claim carries its date and case definition, because that lets readers judge comparability. A table of criteria earns credit when it shows how definitions changed. Faculty value a brief that explains why pooled or older figures cannot be read as current rates. The women's health section is graded on whether it goes beyond the sex ratio to explain consequences, such as delayed recognition. Stating limits clearly, including figures the brief cannot provide, reads as candor, and graders reward it. Sources should be primary criteria papers and systematic reviews.
HLTH 8574 Week 5 help from the desk
Condition briefs often report a single prevalence figure and a sex ratio without saying when or how the cases were counted. Readers then compare numbers that rest on different definitions. To write a stronger brief, find the case definitions or classification criteria used for your condition and note when each changed. Tag every figure with its year and the definition its studies used. If a pooled estimate mixes definitions, say so. Explain why the condition matters for women specifically, for example through symptoms that overlap with other life stages. State which figures you cannot provide and why. A condition brief on the illness your section assigns can be written with every claim dated.
Get a HLTH 8574 Week 5 example written to your instructions
Share the condition your Week 5 prompt assigns, or the shortlist it offers, with the rubric; a condition brief is drafted with each claim dated and its source type named, registry, survey or clinic. No fee for the first custom sample, which reaches you within 24-48 hours with clinical treatment detail left out.
More HLTH 8574 papers and PhD in Public Health samples
- HLTH 8574 Week 1: Population Choice Post
- HLTH 8574 Week 2: Treatment Barrier Post
- HLTH 8574 Week 3: Care Access Analysis
- HLTH 8574 Week 4: Prevalence Evidence Audit
- HLTH 8574 Week 6: Cancer Disparities Memo
- HLTH 8574 Week 7: Maternity Service Map
- HLTH 8574 Week 8: Research History Review
- HLTH 8574 Week 9: Coverage Mandate Critique
- HLTH 8574 Week 10: Evidence Origin Peer Replies
- HLTH 8574 Week 11: Postpartum Heart Care Recommendation
- HLTH 8573 Week 5: Child Determinants Memo
- HLTH 8560E Week 5: Analytic Variable Map
- HLTH 8551 Week 5: Literature Gap Memo
- HLTH 8475 Week 5: Pre-Set Measurement Plan
HLTH 8574 Week 5 questions, answered
Where can I find a free HLTH 8574 Week 5 sample paper?
This page holds the complete Week 5 condition brief on Sjögren's disease, dating and tagging each claim with the classification criteria behind it and comparing the 2002, 2012 and 2016 rules, with four references.
Why tag every claim with classification criteria?
Because Sjögren's disease has been defined differently over time, and studies using different criteria can count different people. A figure from a study using one set may not match a figure from another, so readers need to know which set produced each number.
How much more common is Sjögren's disease in women?
A 2015 meta-analysis estimated a female-to-male ratio of about 9 in incidence data and nearly 11 in prevalence data. The studies used mixed criteria and varied widely by country, so the brief tags the ratio accordingly.
Why choose Sjögren's disease for a women's health brief?
It affects women far more than men, often in midlife, and its symptoms of dryness and fatigue overlap with perimenopause, which can delay testing. It also shows clearly how changing classification criteria shape the evidence.
Does the brief cover treatment?
No. It defines the condition and focuses on burden, distribution and the evidence behind the figures. Treatment belongs to clinical sources and is outside the brief's purpose.